The purpose of this contract, entitled Inhaled Gentamicin Dry-Powder Formulation for Postexposure Prophylaxis and Treatment of Aerosolized Pneumonic Plague and Tularemia, is to develop an inhaled gentamicin, currently the first-line therapy for pneumonic plague and tularemia, as a dry powder formulation in multi-dose inhalers for non-invasive, post-exposure prophylaxis and treatment resulting from aerosol exposure.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$1,000,000
Indirect Cost
Name
Nanotherapeutics, Inc.
Department
Type
DUNS #
073438462
City
Alachua
State
FL
Country
United States
Zip Code
32615